Pluri

Public

Pluri is now publicly traded

The data on this page reflects Pluri's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Feb 4, 2025

Total Funding Raised

$248.68M

Company Overview

Pluri Inc. is a biotechnology company that develops cell-based products for a variety of industries, including regenerative medicine, food technology, and agriculture technology.

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationcell therapy3D cell expansioncell manufacturingregenerative medicinecultivated meatlab-grown meatcellular agriculturebiomanufacturingcell therapy manufacturingplacenta-based cell therapyGMP manufacturingbioreactor systemregenerative aestheticscell-based coffee

Pluri Comparables

Compare Pluri with similar companies based on industry and business-model similarity.

Pluri comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Pluri Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Feb 4, 2025
Private Placement	Jan 23, 2025
Grant	Nov 10, 2021
Debt	May 25, 2021
Follow-on Offering	Feb 2, 2021
Follow-on Offering	May 5, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Yaky Yanay

CEO President

Executive Team

Liat Zalts

Chief Financial Officer

Executive Team

Lior Raviv

Chief Technology Officer, Vice President Development Operations

Executive Team

Pluri Investors

Notable investors and investment history

Pluri investors
Investor	Rounds
MJR PharmJet	Grant
European Commission (Horizon Europe)	Grant
H.C. Wainwright & Co.	Private Placement, Follow-on Offering
Israel Innovation Authority	Grant
Innovative Medical Management Co. Ltd.	Private Placement
European Investment Bank Group	Debt
Vall d'Hebron Research Institute	Grant

View all Investors

Pluri Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pluri Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range253

Year Founded2001

Last FundingFeb 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?